Immunome IMNM
NASDAQ IMNM
$20.89 -0.62 (-2.88%)
As of: Oct 1, 2026 · 3:59 PM EDT

Immunome (IMNM) FCF Margin (2023 - 2025)

Updated

Immunome's FCF Margin was -2890.13% in FY2025, down 1585.33 percentage points from -1304.80% in FY2024.

Analysis

Immunome (IMNM) FCF Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, FCF Margin in earlier years was -1304.80% in FY2024 (-1244.88 pp) and -59.92% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.82%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 18.33%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 26.96%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 43.05%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 34.72%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.70%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 44.00%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 30.39%
10 Immunome 2.44 Bn 410.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,252.95%
Mar 31, 2025 -1,938.48%
Dec 31, 2024 -1,577.28%
Sep 30, 2024 -1,227.01%
Jun 30, 2024 -1,088.87%
Mar 31, 2024 -1,295.82%
Dec 31, 2023 -465.45%
Sep 30, 2023 -242.64%
Jun 30, 2023 -140.93%
Mar 31, 2023 1,018.06%
API Access

Immunome FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=IMNM&period=max&api_key=YOUR_API_KEY